Cargando…

Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus

Chronic kidney disease (CKD) has become a major public health problem in the USA and worldwide. A large majority of patients with CKD have mild to moderate disease and microalbuminuria. It has increasingly been noted that patients with CKD have a significantly higher risk of cardiovascular outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lessey, Gayatri, Stavropoulos, Konstantinos, Papademetriou, Vasilios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709811/ https://www.ncbi.nlm.nih.gov/pubmed/31686830 http://dx.doi.org/10.2147/VHRM.S203925

Ejemplares similares

Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
por: Hsu, Wei-Hao, et al.
Publicado: (2017)

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?
por: Reklou, Andromachi, et al.
Publicado: (2018)

Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials
por: Zhang, Xiao, et al.
Publicado: (2014)

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial
por: Mann, Johannes F. E., et al.
Publicado: (2018)

The Associations between Kidney Function and Sexual Dysfunction among Males and Females with Type 2 Diabetes Mellitus
por: Katsimardou, Alexandra, et al.
Publicado: (2023)

Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
por: Gaziano, Liam, et al.
Publicado: (2022)

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)

Association of type 2 diabetes mellitus and ratio of transmitral E wave velocity to early diastole mitral velocity with cardiovascular events in chronic kidney disease
por: Chen, Po-Chih, et al.
Publicado: (2017)

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011)

Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study
por: Drechsler, Christiane, et al.
Publicado: (2013)

Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients
por: Jeon, Ja Young, et al.
Publicado: (2023)

Carotid intima-media thickness and cardiovascular risk in patients with diabetes mellitus type 2 and chronic kidney disease
por: Kawada, Tomoyuki
Publicado: (2020)

Associations between migraine and major cardiovascular events in type 2 diabetes mellitus
por: Cheon, Dae Young, et al.
Publicado: (2022)

Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
por: Hubbard, Demetria, et al.
Publicado: (2021)

Greater HbA(1c) variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease
por: Lee, Mei-Yueh, et al.
Publicado: (2017)

Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
por: Papademetriou, Vasilios, et al.
Publicado: (2011)

Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities
por: Gajjala, Prathibha Reddy, et al.
Publicado: (2015)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
por: Palanca, Ana, et al.
Publicado: (2019)

Data on the impact of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events
por: Saely, Christoph H., et al.
Publicado: (2018)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
por: Mu, Xiaodie, et al.
Publicado: (2022)

Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease—prospective data from the German Chronic Kidney Disease cohort
por: Ruhe, Johannes, et al.
Publicado: (2023)

Chronic kidney disease in patients with diabetes mellitus
por: Nordheim, Espen, et al.
Publicado: (2021)

Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus
por: LEE, Jen-Chieh, et al.
Publicado: (2021)

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus
por: van der Leeuw, Joep, et al.
Publicado: (2016)

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
por: Zinman, Bernard, et al.
Publicado: (2017)

Living Alone Is Not Associated With Cardiovascular Events and Hypoglycemia in Patients With Type 2 Diabetes Mellitus
por: Zhu, Zhaowei, et al.
Publicado: (2022)

Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
por: Vladu, Mihaela, et al.
Publicado: (2017)

Gestational diabetes mellitus and the role of intercurrent type 2 diabetes on long-term risk of cardiovascular events
por: Sun, Jiyu, et al.
Publicado: (2021)

Acute and chronic kidney complications in children with type 1 diabetes mellitus
por: Rivetti, Giulio, et al.
Publicado: (2022)

The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney Disease
por: Lee, Eunyoung, et al.
Publicado: (2016)

Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
por: Quiroga, Borja, et al.
Publicado: (2022)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2017)

Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
por: Sabe, Marwa A., et al.
Publicado: (2016)

Framingham Risk Score with Cardiovascular Events in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2013)

Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes
por: Beddhu, Srinivasan, et al.
Publicado: (2021)

Cardiovascular Disease in Diabetes and Chronic Kidney Disease
por: Swamy, Sowmya, et al.
Publicado: (2023)

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium
por: Roy, Sion K, et al.
Publicado: (2011)

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease
por: Miller, Paul D, et al.
Publicado: (2022)

ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk
por: Zhang, Hongmei, et al.
Publicado: (2020)

Doubling of serum creatinine and the risk of cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes mellitus: a cohort study
por: Schneider, Cornelia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fee6loaipbmcroc09reopo5m3s